We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

53 hedge funds and large institutions have $139M invested in TriSalus Life Sciences in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 3

333% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 3

20% more funds holding

Funds holding: 44 → 53 (+9)

11% more capital invested

Capital invested by funds: $125M → $139M (+$13.6M)

5.85% more ownership

Funds ownership: 51.77% → 57.62% (+5.8%)

Holders
53
Holders Change
+9
Holders Change %
+20.45%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
15
Reduced
3
Closed
3
Calls
$63K
Puts
–
Net Calls
+$63K
Net Calls Change
+$63K

Top Buyers

Rank Fund Capital Flow
1
VI
Vestcor Inc
New Brunswick, Canada
+$2.29M
2
PMAM
Picton Mahoney Asset Management
Ontario, Canada
+$2.21M
3
MA
MYDA Advisors
New York
+$1.96M
4
JGC
J. Goldman & Co
New York
+$1.83M
5
SV
Starboard Value
New York
+$1.47M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.37M
2
MP
Mangrove Partners
Connecticut
-$966K
3
WRBC
W.R. Berkley Corp
Connecticut
-$240K
4
Morgan Stanley
Morgan Stanley
New York
-$1.23K
5
TRCT
Tower Research Capital (TRC)
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
SV
26
Starboard Value
New York
$1.46M +$1.47M +150,000 New
AA
27
AQR Arbitrage
Connecticut
$1.29M +$664K +67,730 +105%
FTCM
28
Fir Tree Capital Management
New York
$1.22M – – –
DCP
29
Diameter Capital Partners
New York
$1.16M +$948K +96,700 +420%
Hudson Bay Capital Management
30
Hudson Bay Capital Management
Connecticut
$1.14M +$980K +99,999 +588%
Jane Street
31
Jane Street
New York
$871K +$211K +21,491 +31%
MS
32
Maven Securities
Jersey
$789K +$301K +30,681 +61%
Nomura Holdings
33
Nomura Holdings
Japan
$703K – – –
GCL
34
Glazer Capital LLC
New York
$529K +$535K +54,516 New
SCM
35
Segantii Capital Management
Hong Kong
$488K +$490K +50,000 New
COPPSERS
36
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$485K +$490K +50,000 New
WA
37
Whitebox Advisors
Minnesota
$391K +$2.94K +300 +0.8%
OCAM
38
Owl Creek Asset Management
New York
$388K – – –
BCM
39
Basso Capital Management
Connecticut
$353K +$356K +36,343 New
SSA
40
Schonfeld Strategic Advisors
New York
$311K +$137K +14,005 +78%
Millennium Management
41
Millennium Management
New York
$299K +$303K +30,862 New
PI
42
PEAK6 Investments
Illinois
$245K -$88 -9 -0%
TAL
43
TIG Advisors LLC
New York
$237K +$240K +24,464 New
CIC
44
Chilton Investment Company
Connecticut
$194K – – –
TCM
45
Tenor Capital Management
New York
$194K – – –
Geode Capital Management
46
Geode Capital Management
Massachusetts
$181K +$13.1K +1,341 +8%
WMSA
47
Weiss Multi-Strategy Advisers
New York
$104K – – –
LCM
48
Landscape Capital Management
New Jersey
$102K +$103K +10,505 New
ACA
49
Arena Capital Advisors
California
$41K +$41K +4,182 New
UBS Group
50
UBS Group
Switzerland
$11K +$11.1K +1,132 +6,659%
1
2
3

TLSI Hedge Fund Activity: Q2 2021 in Review

53 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q2 2021, worth a combined $139M — up 11% from $125M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new TLSI positions and 3 closed out — a net gain of 10 holders — while 15 added to existing stakes and 3 trimmed.

The largest buyer was Vestcor Inc, adding an estimated $2.29M. The largest seller was Wellington Management Group, cutting an estimated $1.37M.

  • 53 institutional investors held TriSalus Life Sciences (TLSI) as of Q2 2021, up from 44 in Q1 2021.
  • Funds reported $139M of TriSalus Life Sciences stock for Q2 2021, up 11% quarter-over-quarter.
  • 13 funds opened new TriSalus Life Sciences positions in Q2 2021 and 3 closed out, a net change of +10 holders.
  • The largest TriSalus Life Sciences buyer in Q2 2021 was Vestcor Inc, an estimated $2.29M added.
  • The largest TriSalus Life Sciences seller in Q2 2021 was Wellington Management Group, an estimated $1.37M sold.

Based on aggregated 13F filings for Q2 2021.